Danaher Corporation
DHR | NYSE
$215.75
+$3.94 (+1.86%)
At close: Sep 21, 2026, 4:00 PM ET
$215.84
+$0.09 (+0.04%)
After-hours:
Sep 21, 2026, 5:55 PM ET
Company Profile
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
Key Executives
| Name | Position |
|---|---|
| Christopher Paul Riley | Executive Vice President of Biotechnology Group & Chief Executive Officer of Cytiva |
| Rainer Blair | President, Chief Executive Officer & Director |
| Matthew E. Gugino | Chief Financial Officer & Executive Vice President |
| Christopher Bouda | Vice President & Chief Accounting Officer |
| Jose-Carlos Gutierrez-Ramos | Senior Vice President & Chief Science Officer |
| Julie Sawyer Montgomery | Executive Vice President of Diagnostics Platform |
| Martin Stumpe | Chief Technology & AI Officer |
| Matthew R. McGrew | Executive Vice President |
| Mitchell Rales | Co-Founder & Director |
| Rachel Marie Vatnsdal Olson | Vice President of Investor Relations |
| Steven Rales | Co-Founder & Chairman |
Danaher Corporation
| Country | United States |
| IPO Date | Dec 28, 1978 |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Employees | 59,000 |
| CEO | Rainer Blair |
Contact Details
2200 Pennsylvania Avenue, NW Washington,
DC 20037-1701 United States
Stock Details
| Ticker Symbol | DHR |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000313616 |
| CUSIP Number | 235851102 |
| ISIN Number | US2358511028 |
| SIC Code | 3823 |
Recent News
- 6 days ago / prnewswire.comDanaher Announces Quarterly Dividend
- 6 days ago / zacks.comELV or DHR: Which Is the Better Value Stock Right Now?
- 28 days ago / zacks.comDanaher Rides on Strength in Biotechnology Segment: Will It Sustain?
- 1 month ago / defenseworld.netBlackRock Inc. Acquires Shares of 55,084,630 Danaher Corporation $DHR
- 1 month ago / defenseworld.net13,061,264 Shares in Danaher Corporation $DHR Acquired by BlackRock Inc.
- 1 month ago / seekingalpha.comDanaher: 2027 Growth Reacceleration Should Drive Upside
- 2 months ago / prnewswire.comDanaher Appoints Julie Sawyer Montgomery as President and Chief Executive Officer
- 2 months ago / zacks.comCan Danaher (DHR) Climb 32.39% to Reach the Level Wall Street Analysts Expect?
- 2 months ago / barrons.comDon't Quit on Danaher Stock After Horrific Earnings Reaction
- 2 months ago / defenseworld.netDanaher Corporation $DHR Stake Raised by Andra AP fonden
Add to Watchlist
Select watchlists to add or remove DHR